Higher-Order Structure Analysis

Coriolis Pharma offers industry-leading higher-order structure analysis services to ensure the quality, stability and efficacy of your biopharmaceutical products from the onset of R&D. Utilizing our scientific expertise and state-of-the-art technologies, we provide comprehensive structural characterization that supports your formulation development, stability studies and regulatory compliance requirements.

Orthogonal Analysis of the Higher-Order Structure

Coriolis offers an in-depth characterization of biopharmaceutical products’ higher-order structure throughout the development process.

Our expert scientists analyze various aspects of protein structure, including:

  • Secondary structure
  • Tertiary structure
  • Quaternary structure (if applicable)
  • Conformational stability
  • Structural changes under stress conditions (pH, temperature, mechanical stress, freeze-thaw)

We provide orthogonal and sensitive data to comprehensively understand your product’s higher-order structure and behavior under various conditions.

Our higher-order structure services are performed under R&D and/or GMP conditions in dedicated labs with full quality oversight. In addition to protein drugs, these services can also be applied to viruses, cells and viral vectors that fall under biosafety level 2.

Analytical Method Development, Qualification and Validation

For common sample types, we can often apply standardized methods with little setup effort. However, when needed, our experienced analytical experts create or optimize custom methods tailored to your active pharmaceutical ingredient, product type and development phase.

Method Development

Our method development approach tailors sample preparation, method settings and data analysis to the needs of your project and sample.

We include representative samples and, where available, suitable reference standards and stressed/degraded materials, allowing our analytical scientists to design a highly suitable, stability-indicating, robust and repeatable method. Upon request, we will compile a detailed description of the method for your records.

Method Qualification

Method qualification is the initial assessment of an analytical procedure’s performance to show its suitability for its intended purpose.

During method qualification, our analytical scientists perform documented testing demonstrating that the analytical procedure meets criteria in several categories. Criteria may include factors such as repeatability, specificity and robustness. We compile a qualification plan and report, including all relevant data.

Method Validation

Under GMP conditions, method validation confirms that an analytical procedure’s performance suits its intended purpose. Depending on the method’s scope, a broad range of method characteristics, such as specificity, accuracy, precision, limit of detection/limit of quantification (LOD/LOQ), linearity and range, is considered.

During method validation, our analytical scientists perform documented testing demonstrating that the analytical procedure consistently produces a result that meets the predetermined acceptance criteria. We compile a validation plan and report that includes all relevant data.

Depending on the development phase, a fit-for-purpose validation approach can be offered, adjusting the validation required efforts in a phase-appropriate way to meet the method’s needs.

Method Verification

Compendial method verification confirms that a compendial method (e.g., from Ph. Eur. or USP) is suitable and reliable for its intended purpose under the specific conditions of the laboratory.

Unlike full method validation, compendial method verification is often considered a partial validation since the method has already undergone extensive testing and validation during its inclusion in the compendium. The extent of method verification depends on the type of method.

During method verification, our analytical scientists perform documented testing demonstrating that the developed analytical method performs adequately for the specific product or matrix being tested and within the specific laboratory where the method will be employed.

We’ve worked with more than 930 compounds, and that number is growing by the day.

Your Drug Product

Coriolis Pharma’s deep expertise across many biologic modalities, combined with input from world-leading external advisors, offers the knowledge and experience needed to solve even the most complex formulation and drug development challenges.

Your Phase

Our expert team has the expertise and experience to guide your biopharmaceutical development program from preclinical and early-phase development to the market.

Coriolis Effect

See how our expertise and comprehensive services accelerate biologics development from preclinical to the market.

Higher-Order Structure Resources

View All

Talk to Our Experts or Request a Quote

Our expert team is ready to answer your questions and guide you to the services best suited to your program’s modality, stage and challenge. If your needs are well-defined, we’ll begin the quotation process.

Description